Paper6337705
Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.
Mènard S and 4 others. Cancer Res, 1983. Cited by 204 papers, by iCite.
Cite this record
ConductScience Library. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Papers, record 6337705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6337705
- Cell line
- MBr13 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Breast | Major topic |
| Breast Neoplasms | Major topic |
| Animals | |
| Cell Line | |
| Female | |
| Fluorescent Antibody Technique | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Multiple Myeloma | |
| Substrate Specificity |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41799195 | Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathway. | Theranostics | 2026 | https://conductscience.org/library/papers/41799195 | PubMed |
| 40589148 | Blood group O expression in normal tissues and tumors. | FEBS J | 2025 | https://conductscience.org/library/papers/40589148 | PubMed |
| 39311947 | Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors. | Cancer Chemother Pharmacol | 2024 | https://conductscience.org/library/papers/39311947 | PubMed |
| 38305761 | Serum antibody screening using glycan arrays. | Chem Soc Rev | 2024 | https://conductscience.org/library/papers/38305761 | PubMed |
| 36174107 | Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. | Chem Rev | 2022 | https://conductscience.org/library/papers/36174107 | PubMed |
| 35282679 | Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice. | J Am Chem Soc | 2022 | https://conductscience.org/library/papers/35282679 | PubMed |
| 35106375 | Synthesis of Azido-Globo H Analogs for Immunogenicity Evaluation. | ACS Cent Sci | 2022 | https://conductscience.org/library/papers/35106375 | PubMed |
| 33917390 | Application of the Antibody-Inducing Activity of Glycosphingolipids to Human Diseases. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33917390 | PubMed |
| 32893977 | Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32893977 | PubMed |
| 29036791 | Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer. | Cancer Biomark | 2017 | https://conductscience.org/library/papers/29036791 | PubMed |
| 28187738 | Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients. | J Ovarian Res | 2017 | https://conductscience.org/library/papers/28187738 | PubMed |
| 26918109 | A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity. | Chem Sci | 2015 | https://conductscience.org/library/papers/26918109 | PubMed |
| 26257889 | Chemical Synthesis of the Tumor-Associated Globo H Antigen. | RSC Adv | 2015 | https://conductscience.org/library/papers/26257889 | PubMed |
| 23908400 | Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23908400 | PubMed |
| 23355685 | Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23355685 | PubMed |
| 21964054 | Cancer vaccines and carbohydrate epitopes. | Vaccine | 2011 | https://conductscience.org/library/papers/21964054 | PubMed |
| 21423783 | Synthesis of Human Cancer Associated Globo-H (MBr1) Glycosylamino Acid: Some Mechanistic and Conformational Reinvestigations. | Heterocycles | 2009 | https://conductscience.org/library/papers/21423783 | PubMed |
| 21415121 | A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences. | J Lipid Res | 2011 | https://conductscience.org/library/papers/21415121 | PubMed |
| 19874068 | A practical total synthesis of globo-H for use in anticancer vaccines. | J Org Chem | 2009 | https://conductscience.org/library/papers/19874068 | PubMed |
| 19724783 | Immunotherapy for cancer: synthetic carbohydrate-based vaccines. | Chem Commun (Camb) | 2009 | https://conductscience.org/library/papers/19724783 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6337705
GET https://conductscience.org/api/papers/v1/6337705/cited_by?page=2